npj Genomic Medicine (Mar 2017)

A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus

  • Lenha Mobuchon,
  • Aude Battistella,
  • Claire Bardel,
  • Ghislaine Scelo,
  • Alexia Renoud,
  • Alexandre Houy,
  • Nathalie Cassoux,
  • Maud Milder,
  • Géraldine Cancel-Tassin,
  • Olivier Cussenot,
  • Olivier Delattre,
  • Céline Besse,
  • Anne Boland,
  • Jean-François Deleuze,
  • David G. Cox,
  • Marc-Henri Stern

DOI
https://doi.org/10.1038/s41525-017-0008-5
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 7

Abstract

Read online

Cancer: Risk allele identified for melanoma of the eye Researchers have discovered an important genetic risk variant linked to uveal melanoma, a rare malignant tumor of the eye. Marc-Henri Stern from Institut Curie in Paris, France, and colleagues compared more than 860,000 single DNA variants covering the entire genome, from the genomes of 259 people with uveal melanoma and 401 healthy controls, all of whom were of European ancestry. The researchers found that a series of closely linked gene variants on the short arm of chromosome 5 were significantly more common in the melanoma patients. They confirmed the association between this genomic region and disease risk in an independent cohort of 276 cancer cases and 184 controls. Expression analyses showed that the CLPTM1L gene contained in this region was more expressed in people with the risk variants, pointing to CLPTM1L playing a role in tumor development.